Cholic Acid

Cholic Acid

製品名 Cholic Acid
CAS番号 81-25-4
外観 白色からオフホワイトの結晶性粉末
分析(HPLC) ≥98.0%
分子式 C24H40O5
分子量 408.57 g/mol
融点 197–201 °C
比回転 [α]D20 +37° (c=1, ethanol)
溶解度 Soluble in ethanol, acetone; slightly soluble in water
乾燥減量 ≤0.5%
焼失残渣 ≤0.11 TP3T
重金属 10 ppm以下
パッケージ 25 kg fiber drum with inner polyethylene bag

Cholic Acid Structure

同義語: 3α,7α,12α-Trihydroxy-5β-cholan-24-oic acid; Cholan-24-oic acid, 3,7,12-trihydroxy-, (3α,5β,7α,12α)-; Cholic acid; Cholalic acid; 17β-(1-Methyl-3-carboxypropyl)etiocholane-3α,7α,12α-triol

Cholic acid is a primary bile acid biosynthesized in the liver from cholesterol via the classical pathway involving CYP7A1, CYP8B1, and CYP27A1. It is the most abundant bile acid in human bile, typically conjugated with glycine or taurine to form glycocholic and taurocholic acids, which are essential for emulsifying dietary fats and facilitating their absorption in the small intestine. As a pharmaceutical-grade raw material, it serves as a critical starting material for the synthesis of ursodeoxycholic acid (UDCA) and other bile acid derivatives.

Beyond its role in bile acid metabolism, cholic acid has gained significant attention in drug delivery and formulation science. Its amphiphilic nature enables the formation of mixed micelles and liposomes, enhancing the solubility and permeability of poorly water-soluble drugs. In the pharmaceutical industry, it is also used as a choleretic agent and in the treatment of bile acid synthesis disorders. Our cholic acid is manufactured under cGMP conditions, ensuring consistent quality and regulatory compliance for demanding applications.

製品の特長

  • High purity: ≥98.0% by HPLC, with tight control on related substances.
  • Regulatory support: Produced under cGMP; DMF and CEP available upon request.
  • Reliable supply: Annual capacity exceeding 50 metric tons, ensuring uninterrupted supply.
  • Custom packaging: Available in 1 kg to 25 kg quantities to suit R&D and production needs.
  • Technical service: Dedicated support for formulation and regulatory inquiries.

用途

  • Intermediate for ursodeoxycholic acid (UDCA) and other bile acid APIs.
  • Excipient in oral and injectable drug delivery systems to improve bioavailability.
  • Choleretic agent in pharmaceutical preparations for biliary disorders.
  • Reference standard and reagent in biochemical research.
  • Component in cell culture media and liposome formulations.

仕様

パラメータ 仕様
外観 白色からオフホワイトの結晶性粉末
分析(HPLC) ≥98.0%
融点 197–201 °C
比回転 +36° to +38° (c=1, ethanol)
乾燥減量 ≤0.5%
重金属 10 ppm以下
焼失残渣 ≤0.11 TP3T

発注・調達

  • パッケージ: 25 kg fiber drum with double polyethylene liners; custom sizes available.
  • 最小注文数量(MOQ): 1 kg for R&D; 25 kg for commercial orders.
  • リードタイム: 3~5営業日(在庫品)
  • ドキュメント: COA, MSDS, TDS, DMF (upon request), and regulatory support.

見積依頼

  • リブバイオ株式会社. — メールアドレス: info@lyvbio.com

ぜひ連絡を

見積依頼

当社の住所

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×